Back to Results
First PageMeta Content
Biology / Meningococcal vaccine / Meningococcal disease / Neisseria / Vaccination schedule / Pneumococcal conjugate vaccine / Meningitis / MeNZB / Vaccination / Vaccines / Medicine / Health


An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Advice for the use of the Multicomponent Meningococcal Serogroup B (4CMenB) Vaccine
Add to Reading List

Document Date: 2014-04-14 12:08:43

Open Document

File Size: 663,10 KB

Share Result on Facebook

City

Ottawa / /

Company

Grade 6 (since 2003) AB / Meningococcal B Pilot Project Task Group / Novartis / Chiron / Serogroup / PHAC’s National Microbiology Laboratory / THE MULTICOMPONENT MENINGOCOCCAL SEROGROUP / /

Country

Canada / /

/

Event

Product Release / /

IndustryTerm

literature search / /

MedicalCondition

invasive meningococcal disease / fever / hexavalent tetanus diphtheria / septicemia / chronic medical condition / meningococcal disease / meningococcal infection / reportable communicable disease / illness / hearing loss / characteristic non-blanching rash / meningitis / acute febrile illness / serious allergy / /

MedicalTreatment

immunization / amputations / vaccination / /

Movie

Conflict of Interest / /

NaturalFeature

Edward Island / /

Organization

IMD / Public Health Agency of Canada Également / National Advisory Committee on Immunization / Public Health Agency of Canada / IMD in Canada / Canadian Immunization Committee / /

Position

Queen / Minister of Health / Minister of Public Works / /

Product

B (4CMENB) VACCINE / /

ProgrammingLanguage

php / C / /

ProvinceOrState

Prince Edward Island / Ontario / /

Technology

PDF / /

URL

http /

SocialTag